Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Carnegie Fund - Medical Sub-Fund

+ Add to Watchlist

CARMEDI:LX

114.96 EUR 2.22 1.97%

As of 00:59:30 ET on 03/27/2015.

Snapshot for Carnegie Fund - Medical Sub-Fund (CARMEDI)

Year To Date: +20.54% 3-Month: +22.26% 3-Year: +33.51% 52-Week Range: 68.19 - 119.04
1-Month: +4.18% 1-Year: +59.42% 5-Year: +22.01% Beta vs LUXXX: 0.66

Mutual Fund Chart for CARMEDI

No chart data available.
  • CARMEDI:LX 114.96
  • 1M
  • 1Y
Interactive CARMEDI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for CARMEDI

Carnegie Fund - Medical Sub-Fund is an FCP incorporated in Luxembourg. The Fund's objective is long-term capital growth. The Fund invests globally in equities of companies operating in the pharmaceutical, biotechnology and medical technology sectors.

Inception Date: 12-18-1998 Telephone: 352-40-40-30-1
Managers: ANGELICA FATOUROS
Web Site: www.carnegieam.com

Fundamentals for CARMEDI

NAV (on 2015-03-27) 114.96
Assets (M) (on 2015-02-27) 714.71
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment -

Dividends for CARMEDI

No dividends reported

Fees & Expenses for CARMEDI

Front Load -
Back Load -
Current Mgmt Fee 1.70
Redemption Fee -
12b1 Fee -
Expense Ratio -

Top Fund Holdings for CARMEDI

Filing Date: 02/27/2015
Name Position Value % of Total
Gilead Sciences Inc 529,672 48,991,110 6.855%
Johnson & Johnson 413,186 37,943,694 5.309%
Novartis AG 410,862 37,805,944 5.290%
UnitedHealth Group Inc 351,158 35,743,428 5.001%
Amgen Inc 228,638 32,401,621 4.534%
Pfizer Inc 1,036,315 31,959,992 4.472%
Roche Holding AG 128,741 31,428,339 4.397%
Celgene Corp 283,838 31,141,011 4.357%
Carnegie Fund V - The Carnegie 85,642 29,882,113 4.181%
Merck & Co Inc 468,197 24,635,781 3.447%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil